Zobrazeno 1 - 3
of 3
pro vyhledávání: '"59"'
Autor:
Helen Kim, Marie E. Faughnan, K. P. Thompson, Michael T. Lawton, Douglas A. Marchuk, Jeffrey Nelson, Ludmilla Pawlikowska
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-8 (2021)
Orphanet journal of rare diseases, vol 16, iss 1
Orphanet Journal of Rare Diseases
Orphanet journal of rare diseases, vol 16, iss 1
Orphanet Journal of Rare Diseases
Background Retrospective questionnaire and healthcare administrative data suggest reduced life expectancy in untreated hereditary hemorrhagic telangiectasia (HHT). Prospective data suggests similar mortality, to the general population, in Denmark’s
Publikováno v:
Implementation Science, Vol 13, Iss 1, Pp 1-14 (2018)
Implementation science : IS, vol 13, iss 1
Implementation Science : IS
Brookman-Frazee, L; & Stahmer, AC. (2018). Effectiveness of a multi-level implementation strategy for ASD interventions: Study protocol for two linked cluster randomized trials. Implementation Science, 13(1). doi: 10.1186/s13012-018-0757-2. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/0fr4p425
Implementation science : IS, vol 13, iss 1
Implementation Science : IS
Brookman-Frazee, L; & Stahmer, AC. (2018). Effectiveness of a multi-level implementation strategy for ASD interventions: Study protocol for two linked cluster randomized trials. Implementation Science, 13(1). doi: 10.1186/s13012-018-0757-2. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/0fr4p425
Background The Centers for Disease Control (2018) estimates that 1 in 59 children has autism spectrum disorder, and the annual cost of ASD in the U.S. is estimated to be $236 billion. Evidence-based interventions have been developed and demonstrate e
Autor:
Sumida, Yoshio, Yoneda, Masato, Hyogo, Hideyuki, Itoh, Yoshito, Ono, Masafumi, Fujii, Hideki, Eguchi, Yuichiro, Suzuki, Yasuaki, Aoki, Noriaki, Kanemasa, Kazuyuki, Fujita, Koji, Chayama, Kazuaki, Saibara, Toshiji, Kawada, Norifumi, Fujimoto, Kazuma, Kohgo, Yutaka, Yoshikawa, Toshikazu, Okanoue, Takeshi, Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD)
Publikováno v:
BMC Gastroenterology, Vol 12, Iss 1, p 2 (2012)
BMC Gastroenterology
BMC Gastroenterology
Background A reliable and inexpensive noninvasive marker of hepatic fibrosis is required in patients with nonalcoholic fatty liver disease (NAFLD). FIB4 index (based on age, aspartate aminotransferase [AST] and alanine aminotransferase [ALT] levels,